𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Folic acid treatment in methotrexate-treated rheumatoid arthritis patients: comment on the article by Furst and Kremer

✍ Scribed by Sarah L. Morgan; Anthony Saway; Graciela S. Alarcón

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
257 KB
Volume
32
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of folic acid and folinic aci
The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis
✍ Sarah L. Morgan; Robert A. Oster; Jeannette Y. Lee; Graciela S. Alarcón; Joseph 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract ## Objective To determine if folinic acid supplementation during methotrexate (MTX) therapy for rheumatoid arthritis (RA) reduces both urinary 5‐aminoimidazole‐4‐carboxamide (AICA) and urinary adenosine excretion more than does folic acid supplementation. AICA and adenosine are markers

Drug efflux transporters in rheumatoid a
Drug efflux transporters in rheumatoid arthritis: Comment on the article by Kremer
✍ Samantha L. Hider; Patrick Hoggard; Saye Khoo; David Back; Ian N. Bruce 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

We read with interest the article by Kremer (1) reviewing the mechanisms of action of methotrexate (MTX) and potential mechanisms of MTX resistance. One facet that Kremer highlighted is the role of drug efflux transporters in mediating resistance to MTX. Although he highlights the role of multidrug